Medication Costs and Health Care Use in Child Asthma

Published Online: Wednesday, April 18, 2012
In this video, Dana Goldman, PhD, Director of the Schaeffer Center for Health Policy and Economics at the University of Southern California, discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children’s asthma medication. Using insurance claims, the study authors identified 8800 children being treated with long-term asthma medication and then analyzed data about them to establish how often patients filled prescriptions for daily medications and estimated actual medication use. The study authors then compared use of other medical services, including hospital stays and emergency room visits, to determine whether those services were also affected.

Latest Articles
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.
Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.
Losing weight can help decrease the recurrence of atrial fibrillation in overweight patients.
Latest Issues